These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6475942)

  • 1. Oxalate removal by hemodialysis in end-stage renal disease.
    Ramsay AG; Reed RG
    Am J Kidney Dis; 1984 Sep; 4(2):123-7. PubMed ID: 6475942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF; Sadovnic MJ; Cottington EM
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M; Petrarulo M; Mandolfo S; Vitale C; Cosseddu D; Linari F
    Nephron; 1992; 60(1):74-80. PubMed ID: 1738418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolate determination detects type I primary hyperoxaluria in dialysis patients.
    Marangella M; Petrarulo M; Bianco O; Vitale C; Finocchiaro P; Linari F
    Kidney Int; 1991 Jan; 39(1):149-54. PubMed ID: 2002628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
    Ogawa Y; Machida N; Ogawa T; Oda M; Hokama S; Chinen Y; Uchida A; Morozumi M; Sugaya K; Motoyoshi Y; Hattori M
    Urol Res; 2006 Feb; 34(1):12-6. PubMed ID: 16432691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxalate concentration in chronic renal disease.
    Boer P; van Leersum L; Hené RJ; Mees EJ
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of oxalate in hemodialysis].
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW; Veall N; Purkiss P
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
    Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
    Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
    Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM; Chen TW; Lee YH; Chu WY; Young TK
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of oxalate balance in patients on chronic peritoneal dialysis.
    Marangella M; Bagnis C; Bruno M; Petrarulo M; Gabella P; Linari F
    Am J Kidney Dis; 1993 Apr; 21(4):419-26. PubMed ID: 8465823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.